• There are no suggestions because the search field is empty.

Handling Medical Information Requests and Enquiries: A Scientific Services Guide

person-image
Ana María González Fuente, Senior Consultant Medical Information at QbD Group

Learn how to handle medical information requests and enquiries in line with EU and local pharma regulations. Best practices for scientific services teams.

Guide to Medical Information Requests and Enquiries | QbD Group
10:41

What do you do when a healthcare professional emails your company about off-label use

  • Or when a patient wants clarity on a side effect they’ve experienced?
  • Or when a patient isn’t sure how to operate their medical device?
  • Or when a patient forgets a dose and needs guidance?
  • Or when a pharmacist runs into problems with the storage and stability of your product?

These aren’t just routine inquiries — they’re Medical Information Requests (or Medical Enquiries), and the way you handle them can shape everything from your compliance status to brand trust.

In today’s highly regulated pharmaceutical environment, every request is a moment of truth. They test not only your scientific credibility, but also your ability to respond clearly, compassionately, and in full compliance with national and European regulations.

In this post, we’ll walk you through the lifecycle of a medical enquiry, highlight the skills and systems you need to manage them effectively, and show how a simple question can evolve into a critical regulatory touchpoint.

What are Medical Information Requests (Medical Enquiries)?

A Medical Information Request—also known as a Medical Enquiry—is a spontaneous question or request for scientific information about a company’s medicinal products or related therapeutic areas. These requests can be submitted by:

  • Healthcare professionals
  • Patients
  • Consumers
  • The general public
  • Healthcare organizations
  • Other stakeholders

They may cover topics from dosage and drug–drug interactions to use in special populations, off-label questions, device operation, storage and stability, or side-effect clarifications, and can arrive via email, phone, medical representatives, or digital platforms.

These activities fall under the responsibility of a company’s scientific services or its marketing authorization holder and must comply with:

 

  • EU Directive 2001/83/EC (as amended)
  • Applicable national laws (e.g., Spain’s Law 29/2006; Royal Decree 1345/2007)
  • Promotion-related safeguards (e.g., Royal Decree 1416/1992; local circulars such as Pharmacy Circular No. 1/2000 in Madrid)
  • Industry codes and guidelines (e.g., EFPIA Code of Practice)

The guiding principles? Responses must be scientifically accurate, objective, and non-promotional, and — importantly — tailored in tone and level of detail to the recipient, always prioritizing patient safety and healthcare professional autonomy.

Why medical enquiries deserve strategic focus

While responding to medical enquiries is a regulatory requirement, it’s also a unique opportunity to showcase your company’s deep therapeutic expertise and strengthen your brand as a scientifically responsible partner. Done well, this process can:

  • Demonstrate deep knowledge and expertise in the relevant therapeutic area
  • Reinforce trust among healthcare professionals and patients by providing clear, tailored guidance
  • Support clinicians in their day-to-day practice with balanced, evidence-based information
  • Empower patients to use your products safely and effectively
  • Highlight regulatory competence through consistent, compliant processes

In short: it’s not just about compliance. It’s about credibility, expertise, and real-world impact.

Regulatory landscape: turning compliance into clarity

You know that medical enquiries fall under your scientific services and are governed by a patchwork of EU and local laws. But how can you use that framework to your advantage?

  • EU Directive 2001/83/EC mandates a dedicated scientific service for product-related information at the European level.
  • National laws (e.g., Spain’s Guarantee Law 29/2006; Royal Decree 1345/2007) and promotion-related safeguards (e.g., Royal Decree 1416/1992) layer on requirements for non-promotional, science-based communication.
  • Industry codes (for instance, the EFPIA Code of Practice) further guide tone and transparency.

Rather than seeing these rules as restrictions, the most successful companies leverage them to build consistent, credible processes—from triage and evidence review to documentation and follow-up—ensuring every response is scientifically accurate, objective, and tailored in tone and depth to the recipient.

A well-understood regulatory foundation not only satisfies auditors but also fosters internal clarity, external trust, and reinforces your role as a true scientific partner to healthcare professionals and patients alike.

The medical enquiry lifecycle: from question to confidence

Let’s look at the typical journey of a medical enquiry and what it takes to respond appropriately at each stage.

1. Submission & triage

Requests are received through various channels—contact centers, field reps, websites—and must be classified correctly. A crucial first step is distinguishing the type of requester (HCP, patient, other) and the nature of the question (on-label, off-label, urgent, etc.).

Correct triage ensures that requests are handled efficiently and routed to the right experts, minimizing delays and regulatory risk.

2. Research & information gathering

The medical information team collects data to craft an accurate response.

  • For patients, responses are based on the SmPC (Summary of Product Characteristics) and patient leaflet.
  • For HCPs, information may extend beyond the label, based on peer-reviewed literature and clinical data.

This may involve: 

  • Bibliographic searches in scientific databases (e.g. PubMed, Embase)
  • Use of keywords, MeSH terms, Boolean operators
  • Critical reading of primary sources to extract relevant, balanced data

Tailoring responses to the audience while maintaining scientific integrity is essential for compliance and impact.

3. Internal review & approval

Draft responses undergo review by cross-functional stakeholders—medical, legal, and regulatory—to ensure scientific objectivity, policy compliance, and legal soundness. Comprehensive audit trails are maintained for inspection readiness.

Robust internal oversight provides full traceability and safeguards against risks of non-compliant promotional messaging, reinforcing both regulatory integrity and brand credibility.

4. Response delivery & feedback

The final response is sent in a clear, well-referenced format appropriate for the requester. Many companies also include a feedback loop to assess satisfaction and improve the process.

A professional, audience-appropriate response enhances credibility, and every interaction is a chance to learn and improve.

Building a world-class medical information team

Delivering top-notch medical information requires more than subject-matter knowledge; it demands a blend of specialized skills and competencies:

  • Deep Therapeutic & Industry Expertise: Team members must understand the nuances of the therapeutic-area landscape, product portfolios, and the broader pharmaceutical environment — anticipating laboratory and clinical practice needs.
  • Advanced Literature-Search Mastery: Proficiency with key scientific databases (PubMed, Cochrane Library, Embase) and search tools — MeSH terms, subheadings, Boolean operators, and database algorithms — ensures fast, comprehensive evidence retrieval.
  • Critical Appraisal & Evidence Synthesis: The ability to evaluate study design, detect bias, and distill complex data underpins truly evidence-based responses.
  • Strategic Communication & Stakeholder Support: Crafting scientifically accurate, audience-appropriate messages that reinforce clinical decision-making for HCPs and guide patients in safe, effective product use.

Investing in these capabilities not only elevates response quality but also builds the robust processes you need to handle complex or novel enquiries with confidence and full compliance.

High-quality medical information isn’t just expertise — it’s grounded in rigorous policy adherence and scientific integrity. By ensuring every response is accurate, reliable, and fully aligned with regulations, you reinforce your credibility and trustworthiness in the eyes of healthcare professionals, patients, regulators, and consumers.

Turning enquiries into brand-building opportunities

Medical information requests aren’t just service interactions—they’re moments to reinforce your scientific integrity and corporate reputation:

  • Timeliness demonstrates commitment: Rapid turnaround times show stakeholders their concerns truly matter.
  • Scientific rigor prevents bias: Delivering balanced, evidence-based information—with clear acknowledgment of both benefits and limitations—ensures accuracy and objectivity.
  • Transparency builds confidence: Citing sources, methodologies, and data provenance underscores your dedication to scientific integrity.
  • Consistency reflects excellence: Applying uniform processes across all enquiries highlights operational rigor, reliability, and compliance.

By viewing each enquiry as a brand engagement, you cultivate lasting trust and differentiate your organization in a competitive market.

How QbD Group can support your medical information processes

QbD Group offers end-to-end support for handling Medical Information Requests and Enquiries, ensuring every response is compliant, scientifically sound, and strategically aligned:

  • Regulatory Alignment: Our processes are meticulously designed to satisfy EU and national legislation, including anti-promotion safeguards.
  • Scientific Excellence: Leveraging our team of seasoned medical writers and researchers, we conduct thorough literature reviews and produce high-quality, well-referenced reports.
  • Operational Efficiency: With streamlined workflows, audit-ready documentation, and real-time KPI tracking, we ensure your enquiries are handled promptly and transparently.
  • Tailored Engagement: Whether your audience is patients, HCPs, or organizational stakeholders, we adapt our communication style and depth to meet their specific needs.

Ready to transform your medical enquiry process into a strategic asset?

Contact QbD Group today to discover how we can help you strengthen your Medical Information Requests and Medical Enquiries—from regulatory compliance to scientific excellence.

Contact QbD Group today to discover how we can help you strengthen your Medical Information Requests and Medical Enquiries—from regulatory compliance to scientific excellence.

 

Stay ahead in life sciences

Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.

Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.

Circles-banner-short

Discover more expert content

preview_image
Whitepaper

Digitalization in the Pharmaceutical Industry: And How to Stay Compliant

Digitalization and Pharma 4.0 drive digital transformation. Explore the role of CSV in pharma's digital journey.
preview_image
Whitepaper

The Essential CSV & Digitalization FAQ for Life Sciences Companies

Get clear answers to real CSV questions from clients & experts. Download our FAQ and stay compliant, audit-ready, and confident in your Software Validation Strategy.
preview_image
Whitepaper

Audit Trail Review in GxP Environments

Learn how to implement a risk-based Audit Trail review strategy to enhance software compliance in GxP environments.
preview_image
Case study

Validating a Complex Autoclave Load to Enhance Sterilization Efficiency

Discover how QbD Group helped a pharmaceutical facility in Barcelona optimize and validate a complex autoclave load, improving sterilization efficiency and manufacturing flexibility.
preview_image
Case study

Fast-Tracked Site Qualification for Clinical Trial Submission

QbD Group helped a biotech company complete 5 site qualification visits in just 3 weeks enabling a timely and compliant clinical trial submission.
preview_image
Webinar

Pharmacovigilance and Risk Management in Innovative Therapies: A Challenge in Drug Safety

Explore pharmacovigilance in cell, CAR T, and RNA therapies. Join our webinar to tackle tomorrow’s drug safety and risk management challenges.
preview_image
Webinar

Extractables & Leachables in Pharma: Navigating Evolving Regulations and Toxicological Challenges

This webinar aims to provide a comprehensive overview of Extractables and Leachables (E&L) in pharmaceutical products, highlighting regulatory complexities, toxicological challenges, and practical approaches to study design and risk assessment across the product lifecycle.
preview_image
Whitepaper

A Complete Guide to Computer System Validation

This guide aims to bring context and define the necessary and appropriate strategies for the validation of computerized systems. Download now.
preview_image
Whitepaper

Digital Health - Exploring the landscape and future opportunities

This whitepaper informs you about digital health, key technology pillars, and new opportunities to anticipate future trends in your healthcare sector.
preview_image
Whitepaper

ISO 13485:2016 - Compliance Checklist

Are you up to date with the latest medical device QMS requirements? Download our free ISO 13485:2016 checklist to ensure compliance.
preview_image
Case study

Enhancing data integrity & aseptic manufacturing compliance

QbD Group helped a leading medical tech company improve MDR compliance and enhance aseptic manufacturing for long-term regulatory readiness.
preview_image
Case study

A Decade of Excellence: Linguistic Review Support for a Global Pharma Leader​

QbD Group streamlines linguistic reviews for a leading pharma client, ensuring compliance and accuracy across 25 EU/EEA languages while meeting stringent regulatory deadlines.
preview_image
Whitepaper

ICH Stability Studies on Pharmaceuticals

This whitepaper discusses the importance of different methods for testing the stability of pharmaceutical products, stability study guidelines, and other aspects related to the stability of pharmaceutical products.
preview_image
Whitepaper

EU GMP: How to import your products into the EU?

Are you a medicinal product manufacturer looking to import your products into the EU in line with the latest EU-GMP import regulations? Download our guide.
preview_image
Case study

Scalable MSAT validation support for seamless compliance & efficiency

Discover how QbD Group helped a global pharmaceutical company address fluctuating validation demands across multiple teams.
preview_image
Case study

Restoring manufacturing timelines through expert deviation management

Discover how QbD Group helped a leading biotechnology company overcome a backlog of deviations, restoring timely batch release through expert QA support.
preview_image
Case study

Guiding a global biotech company through ATMP facility qualification

Discover how QbD Group supported a global biotech company in commissioning and qualifying two ATMP therapy production sites, ensuring compliance and efficiency.
preview_image
Whitepaper

How to keep computerized systems in the operational phase

Ensure compliance and efficiency with best practices for maintaining computerized systems in the operational phase. Download our expert whitepaper now!
preview_image
Whitepaper

Medical Device Regulation (MDR) Checklist

Implement the Medical Device Regulation (MDR) with ease. Download our checklist of mandatory documents for MDR compliance.
preview_image
Webinar

Evidence Throughout the Lifecycle: Integrating Clinical Needs into Design & Documentation

Discover how to integrate clinical needs into medical device software design to meet MDR requirements. Watch our webinar on demand.
preview_image
Whitepaper

Regulatory Affairs for Pharma and Biotech

In this flyer, you will learn more about the regulatory services QbD Group provides for the pharmaceutical and biotechnology industries.
preview_image
Webinar

From Requirements to Code: a unified MDSW development cycle that covers all requirements

Watch our webinar on demand to master medical device software development. Learn about IEC standards, cybersecurity, AI integration, and FDA expectations.
preview_image
Whitepaper

Clinical Evaluation for Medical Devices under MDR

This whitepaper will guide you through crucial regulatory documents pertaining to the clinical evaluation process of your medical device. Download now!
preview_image
Whitepaper

IVDR extension: what does this mean for you?

In this whitepaper, you will learn the impact of the IVDR transition extension and receive tips and strategies to navigate these regulatory changes.
preview_image
Webinar

From Concept to Market: Comprehensive Market Access Strategies for Medical Device Software

Learn how to launch your Medical Device Software successfully with expert insights on market access and commercialization strategies. Watch our webinar on demand.
preview_image
Whitepaper

State-of-the-art literature review: kick off the Clinical Evaluation of your Medical Device

This whitepaper will walk you through the steps of conducting solid systematic SOTA literature searches for your clinical evaluation. Download now.
preview_image
Webinar

Drug-Device Combination Products and Article 117

Explore the regulatory complexities of Drug-Device Combination Products. Learn about Article 117 requirements, Notified Body Opinions, and more.
preview_image
Whitepaper

Mobile health on the rise: exploring the regulatory landscape for reimbursement

This whitepaper will help you navigate the maze of the DTx regulatory environment, highlighting several important countries and regulations.
preview_image
Whitepaper

Clinical investigations under MDR: key insights and practical experiences

This whitepaper covers clinical investigation authorization under MDR, the EU Legal Representative's role, and the MDR's impact on study conduct and post-market surveillance.
preview_image
Whitepaper

The pathway from idea to patient under MDR

This guide explains the pathway and steps needed to test your device in human subjects, aiming to get your product to market. Download now.
preview_image
Webinar

Unlocking Strategic Value in Drug Safety for Life Sciences Organizations

Explore how drug safety teams can transform into proactive benefit drivers with the right tools & resources in this webinar on demand.
preview_image
Case study

CE Mark Renewal for bioXtra Products: A Success Story

Discover how Lifestream Pharma successfully renewed the CE mark for their BioXtra Dry Mouth products under the EU MDR. Learn about the challenges faced, the approach taken for compliance, and the results achieved.
preview_image
Webinar

Technical Documentation Essentials for Medical Device Software

Gain practical insights on crafting MDR-compliant technical documentation for Medical Device Software.
preview_image
Whitepaper

GAMP 5 Software Validation Approach for GMP, GCP and GLP regulations

Learn how to comply with GMP, GCP, and GLP regulations using the GAMP 5 Software Validation Approach. Download the whitepaper for more insights.
preview_image
Webinar

How to manage mandatory communication of Toxicological Risks?

Learn how to effectively manage toxicological risks in the pharmaceutical industry by addressing, reporting, and mitigating potential harm.
preview_image
Webinar

Getting Started: Overcoming Initial Obstacles in Medical Device Software Development

Watch our webinar on demand and learn about regulatory obstacles, MDR, AI Act, and best practices for medical device software development and market entry.
preview_image
Whitepaper

Standards and regulations for software used in Medical Devices

Explore the essential standards and regulations for software used in Medical Devices, including IEC 62304 and IEC 82304. Download now.
preview_image
Webinar

Setting up ATMP Quality Management Systems: Strategies for Compliance and Success

Discover strategies for establishing a compliant and successful ATMP Quality Management System. Watch our webinar on demand.
preview_image
Webinar

Mastering Clinical Performance Studies under IVDR

In the evolving regulatory landscape of IVDs, demonstrating clinical performance is more crucial and challenging than ever. Discover more in this webinar on demand.
preview_image
Webinar

The Basic Concepts of the QbD Methodology

Learn the basics of QbD methodology with industry experts in this on-demand webinar.
preview_image
Whitepaper

Clinical evidence for In Vitro Diagnostics under IVDR

In this whitepaper, we will guide you through the documents required for the demonstration of clinical evidence under the IVDR. Download now.
preview_image
Webinar

ATMP Supply Chain: Navigating the Challenges and Exploring the Vein-to-Vein Strategy

Explore the transformative ATMP journey and vein-to-vein strategy in our webinar. Learn how to navigate challenges and unlock the full potential of ATMPs.
preview_image
Whitepaper

Achieving laboratory compliance

This whitepaper explores the multifaceted aspects of laboratory compliance, including data integrity, quality control measures, and regulatory adherence.
preview_image
Whitepaper

Annual Product Quality Review in Pharma

Want to learn more about the importance, benefits, and key challenges related to the Annual Product Quality Review in Pharma? Then read on quickly!
preview_image
Whitepaper

New GMP Facility Qualification: set-up, process and best practices

This whitepaper delves into the challenges of establishing a new GMP facility, focusing on potential pitfalls and best practices. Download now.
preview_image
Whitepaper

The One-Vigilance strategic roadmap to corporate excellence

This whitepaper introduces the concept of One Vigilance within the context of the current drug safety landscape. Download now.
preview_image
Case study

Guiding KU Leuven's glioblastoma research to the clinic with precision business planning

Helping KU Leuven advance glioblastoma research to the clinic with strategic business planning, funding support, and a roadmap for clinical impact.
preview_image
Webinar

Post-Market Surveillance Requirements for Medical Devices and IVDs

Learn about post-market surveillance requirements under MDR and IVDR regulations. Gain insights from industry experts in this on-demand webinar.
preview_image
Whitepaper

21 CFR Part 11 compliance checklist

Want to assess whether a computer system generates electronic records and uses electronic signatures, and whether the system complies with Part 11 of 21 CFR? Download this free checklist.
preview_image
Whitepaper

Ensuring compliance and quality in Pharmacovigilance

The whitepaper emphasizes the importance of a robust pharmacovigilance QMS and a well-maintained Pharmacovigilance System Master File (PSMF). Download now.
preview_image
Webinar

Second edition of GAMP 5: A Risk-Based Approach to compliant GxP Computerized Systems

This webinar on demand will tell you more about the second edition of GAMP 5.
preview_image
Whitepaper

Organic and mutagenic impurities in pharma

Ensure pharmaceutical quality and safety by controlling organic and mutagenic impurities. Download this whitepaper to learn more.
preview_image
Whitepaper

The key role of Regulatory Affairs in the pharmaceutical industry: from drug development to commercialization

Discover the key role of Regulatory Affairs in pharma and how Regulatory Affairs teams support product lifecycle management in this whitepaper. Download now.
preview_image
Webinar

Verification & Validation of Artificial Intelligence/ Machine Learning Medical Devices

Explore the impact of Artificial Intelligence and Machine Learning on medical device validation and verification processes.
preview_image
Whitepaper

GAMP categories for computerized systems: what are they and what are they for?

In this whitepaper, you will learn what GAMP is, what GAMP categories are for, and where to start if you are facing computerized systems validation.
preview_image
Whitepaper

Analytical Method Validation

In this whitepaper, we will give an overview of the criteria to consider when validating your analytical method.
preview_image
Whitepaper

EUDRALEX Volume 4 Annex 11 Compliance Checklist

Assess your computer system's compliance with EudraLex Volume 4 Annex 11 guidelines using our checklist. Download now for GMP assurance.
preview_image
Webinar

3D Printing in the Healthcare World

Explore the challenges and opportunities of 3D printing in healthcare, featuring expert insights on regulations, pitfalls, and efficiency.
preview_image
Whitepaper

From V-model to Agile: how to embrace automation as part of the computerized system validation approach

This white paper explores why IT is shifting to agile, focuses on the prevalent Scrum methodology, and concludes with guidance on adapting system validation processes.
preview_image
Webinar

IVDR Extension Explained: Tips & Strategies

Gain valuable insights on the IVDR extension and its impact on IVD manufacturers with our webinar on demand.
preview_image
Whitepaper

Innovations in ATMP: state of the industry in 2024

This whitepaper explores the innovations in ATMP and solutions in detail, with a focus on the current landscape as of April 2024. Download now.
preview_image
Case study

Optimizing pharmacovigilance for a biotechnology leader

Discover how QbD Group improved pharmacovigilance for a global leader in biotechnology, ensuring regulatory compliance and patient safety.
preview_image
Case study

Ensuring timely launch: QbD Group's role in establishing a hemophilia drug production line

QbD Group has facilitated the launch of a new drug production line for treating hemophilia, overseeing the qualification of over 100 pieces of small-scale supporting equipment.
preview_image
Case study

Ensuring pharmaceutical production quality: cleaning validation for government agency

Discover how QbD Group helped a client tackle dual validation challenges for their production lines, ensuring GMP compliance and AEMPS approval.
preview_image
Case study

Revolutionizing pharmacovigilance: a success story of strategic partnership and seamless integration

Discover how QbD Group's expert support enhanced a pharmaceutical company's pharmacovigilance, leading to a favorable inspection outcome by the local Regulatory Authority (AEMPS).
preview_image
Case study

The journey toward IVDR compliance for the LVOne device

QbD Group helped Upfront Diagnostics gain entry into the MD/IVD industry by supporting them on their path to ISO 13485 certification.
preview_image
Case study

Patient Support Program (PSP)

Learn about our patient support program (PSP) and how it helps manage customer support for a PV Spanish client. Resolve quality issues and ensure stability with QbD Pharma.
preview_image
Case study

Ensuring a smooth MDR transition for Oystershell's medical devices

The landscape of medical device regulations is constantly evolving, making it a challenge for companies to keep up. Our collaboration with Oystershell, which began in July 2023, highlights our expertise in transforming complex challenges into success stories, all with a touch of QbD Clinical magic.
preview_image
Case study

Successful clinical evaluation supports rapid CE marking of Minze Health's Uroflowmeter

QbD Clinical assisted Minze Health, a urology-focused medical devices company, in obtaining CE marking under MDR through clinical evaluation.
preview_image
Webinar

The Medical Device CE Certification Pathway Explained: From Classification to Conformity Assessment by the Notified Body

Learn about the Medical Device CE Certification Pathway, from classification to conformity assessment by a Notified Body. Join our webinar on demand.
preview_image
Case study

Helping Relu to comply with changing regulations

QbD Group supported software company Relu with their expertise to comply with changing regulations.
preview_image
Case study

Helping Abraca BioSystems to obtain ISO 13485 certification

QbD Group helped Abraca Biosystem gain entry into the MD/IVD industry by supporting them on their path to ISO 13485 certification.
preview_image
Case study

Help BioLizard build their Quality Management System

QbD Group helped BioLizard document the fundamental processes of their QMS and enabled them to continue building it on their own.
preview_image
Case study

Supporting Oncomfort in developing and certifying their ISO 13485 QMS

QbD Group helped Oncomfort quickly implement and certify an ISO 13485 compliant Quality Management System.
preview_image
Case study

Quickly bringing a new COVID-19 medical device to market

Obtaining the required government certifications for a medical device is always a challenge. Especially when the COVID clock is ticking.
preview_image
Blog

Environmental Risk Assessment (ERA) in Drug Products: Understanding the New EMA Guideline Updates

Balancing human health, regulatory compliance, and environmental...
preview_image
Blog

Outsourced QA: Benefits, Risks, and Long-Term Impact

Balancing efficiency, cost, and compliance is a growing challenge...
preview_image
Blog

IVDR Compliance for Large-Panel Next-Generation Sequencing (NGS) Devices: A Strategic Guide

Next-Generation Sequencing (NGS) has revolutionized precision...
preview_image
Blog

Life Sciences Digitization: Your Compliance Roadmap

In the ever‑evolving life sciences industry, digitization is no longer...
preview_image
Blog

QbD Group welcomes Dr. Diane Fairweather as Division Head Clinical

A proven track record in global clinical leadership Diane’s career began in...
preview_image
Blog

QbD Group awarded Gold Label as Best Managed Company 2025

We’re proud to share that QbD Group has once again been recognized as one of...
preview_image
Blog

Dr. Angeles Escarti-Nebot joins QbD Group as Division Head Regulatory Affairs

Navigating complexity with purpose and clarity Angeles has built her career...
preview_image
Blog

Azierta fully integrated into QbD Group

{% video_player "embed_player" overrideable=False, type='hsvideo2',...
preview_image
Blog

QbD Group unveils evolved brand identity, reflecting strategic evolution and vision for the future

A brand that evolves with our clients Over the years, QbD Group has...
preview_image
Blog

Expanded eIFU Eligibility under EU Regulation 2025/1234

Expanded rules for electronic instructions for use (eIFUs) Effective:...
preview_image
Blog

FDA Deadline Update - Risk of nitrosamine drug substance-related impurity (NDSRI)

Key takeaways from the update: Confirmatory testing and risk evaluation must...
preview_image
Blog

4 key guidance documents released under the EU MDR and IVDR frameworks

MDCG 2025-5 clarifies essential aspects of IVD performance studies, including...
preview_image
Blog

Launch of the first phase of the COMBINE Project 1 pilot - "all-in-one” coordinated assessment

Sponsors can now submit a single application for trials involving both a...
preview_image
Blog

Nitrosamines Update EMA/409815/2020 Rev.22

What is new? In the latest EMA Q&A Rev.22 update, the same risk-based...